Evidence that the bulge region is a site of relative immune privilege in human hair follicles

British Journal of Dermatology

Volumn 159, Issue 5, 2008, Pages 1077-1085

  Meyer, K C ^a   Klatte, J E ^a,b   Dinh, H V ^c   Harries, M J ^a,d   Reithmayer, K ^a   Meyer, W ^e   Sinclair, R ^c   Paus, R ^a,d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Bulge; HLA E; Human hair follicles; Immune privilege; Indoleamine 2,3 dioxygenase; Macrophage migration inhibitory factor

Indexed keywords

ALPHA INTERMEDIN; BETA 2 MICROGLOBULIN; GAMMA INTERFERON; HLA A ANTIGEN; HLA E ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ALOPECIA; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; FEMALE; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IMMUNITY; PRIORITY JOURNAL; SCALP; SKIN CULTURE; STEM CELL;

BETA 2-MICROGLOBULIN; DOWN-REGULATION; HAIR FOLLICLE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; SCALP;

EID: 54249128963     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08818.x     Document Type: Article

References (59)

1. Paus R, Christoph T, Muller-Rover S. Immunology of the hair follicle: a short journey into terra incognita. J Investig Dermatol Symp Proc 1999 4 : 226 34.
2. Paus R, Nickoloff BJ, Ito T. A 'hairy' privilege. Trends Immunol 2005 26 : 32 40.
3. Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006 5 : 64 9.
4. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007 117 : 2019 27.
5. Niederkorn JY. Mechanisms of immune privilege in the eye and hair follicle. J Investig Dermatol Symp Proc 2003 8 : 168 72.
6. Wahl SM, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 2006 213 : 213 27.
7. Simpson E. A historical perspective on immunological privilege. Immunol Rev 2006 213 : 12 22.
8. Cobbold SP, Adams E, Graca L et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev 2006 213 : 239 55.
9. Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol 2006 126 : 1459 68.
10. Morris RJ, Liu Y, Marles L et al. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 2004 22 : 411 17.
11. Tumbar T, Guasch G, Greco V et al. Defining the epithelial stem cell niche in skin. Science 2004 303 : 359 63.
12. Ohyama M, Terunuma A, Tock CL et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006 116 : 249 60.
13. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 2006 7 : 354 9.
14. Siglienti I, Chan A, Kleinschnitz C et al. Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. J Neuropathol Exp Neurol 2007 66 : 47 56.
15. Rosenblum MD, Olasz EB, Yancey KB et al. Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? J Invest Dermatol 2004 123 : 880 7.
16. Rosenblum MD, Yancey KB, Olasz EB et al. CD200, a 'no danger' signal for hair follicles. J Dermatol Sci 2006 41 : 165 74.
17. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999 341 : 491 7.
18. Tiede S, Kloepper JE, Bodo E et al. Hair follicle stem cells: walking the maze. Eur J Cell Biol 2007 86 : 355 76.
19. Harrist TJ, Ruiter DJ, Mihm MC Jr. et al. Distribution of major histocompatibility antigens in normal skin. Br J Dermatol 1983 109 : 623 33.
20. Paus R, Eichmuller S, Hofmann U et al. Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol 1994 131 : 177 83.
21. Paus R, van der Veen C, Eichmuller S et al. Generation and cyclic remodeling of the hair follicle immune system in mice. J Invest Dermatol 1998 111 : 7 18.
22. Christoph T, Muller-Rover S, Audring H et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000 142 : 862 73.
23. Janeway C. Immunobiology, 6th edn. New York : Garland Science, 2005.
24. Paus R, Ito N, Takigawa M et al. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003 8 : 188 94.
25. Lu Z, Hasse S, Bodo E et al. Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 2007 16 : 37 44.
26. Ito T, Ito N, Bettermann A et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004 164 : 623 34.
27. Roth KA, Adler K, Bobrow MN. Enhanced tyramide signal amplification immunohistochemical detection. J Histochem Cytochem 1999 47 : 1644 5.
28. Ito T, Ito N, Saathoff M et al. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 2005 125 : 1139 48.
29. Kloepper JE, Hendrix S, Bodo E et al. Functional role of beta 1 integrin-mediated signalling in the human hair follicle. Exp Cell Res 2008 314 : 498 508.
30. Ito T, Ito N, Saatoff M et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 2008 128 : 1196 206.
31. Coupel S, Moreau A, Hamidou M et al. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007 109 : 2806 14.
32. Niederkorn JY. Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 2002 22 : 13 46.
33. Apte RS, Sinha D, Mayhew E et al. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 1998 160 : 5693 6.
34. Baban B, Chandler P, McCool D et al. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 2004 61 : 67 77.
35. Hainz U, Jurgens B, Heitger A. The role of indoleamine 2,3-dioxygenase in transplantation. Transpl Int 2007 20 : 118 27.
36. Kwidzinski E, Bechmann I. IDO expression in the brain: a double-edged sword. J Mol Med 2007 85 : 1351 9.
37. Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007 117 : 1147 54.
38. Moscoso J, Serrano-Vela JI, Pacheco R et al. HLA-G, -E and -F: allelism, function and evolution. Transpl Immunol 2006 17 : 61 4.
39. Yip L, McCluskey J, Sinclair R. Immunological aspects of pregnancy. Clin Dermatol 2006 24 : 84 7.
40. Le Discorde M, Moreau P, Sabatier P et al. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003 64 : 1039 44.
41. Niederkorn JY, Chiang EY, Ungchusri T et al. Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 1999 68 : 1790 9.
42. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998 391 : 795 9.
43. Tripathi P, Naik S, Agrawal S. HLA-E and immunobiology of pregnancy. Tissue Antigens 2006 67 : 207 13.
44. Gao GF, Tormo J, Gerth UC et al. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 1997 387 : 630 4.
45. Pacasova R, Martinozzi S, Boulouis HJ et al. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice. J Immunol 1999 162 : 5190 6.
46. Ulbrecht M, Honka T, Person S et al. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 1992 149 : 2945 53.
47. Swanson KA, Zheng Y, Heidler KM et al. CD11c+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 2004 30 : 311 18.
48. Li Y, Tredget EE, Ghaffari A et al. Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J Invest Dermatol 2006 126 : 128 36.
49. von Bubnoff D, Bausinger H, Matz H et al. Human epidermal Langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. J Invest Dermatol 2004 123 : 298 304.
50. Chen PW, Mellon JK, Mayhew E et al. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Exp Eye Res 2007 85 : 617 25.
51. Mellor AL, Munn DH. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 2008 8 : 74 80.
52. Fallarino F, Vacca C, Orabona C et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int Immunol 2002 14 : 65 8.
53. Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998 281 : 1191 3.
54. Taylor AW, Kitaichi N. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav Immun 2008 22 : 639 46.
55. Vigano P, Cintorino M, Schatz F et al. The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface. Semin Immunopathol 2007 29 : 135 50.
56. Shimizu T, Ohkawara A, Nishihira J et al. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization. FEBS Lett 1996 381 : 199 202.
57. Arcuri F, Cintorino M, Carducci A et al. Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor. Reproduction 2006 131 : 175 82.
58. Ruckert R, Hofmann U, van der Veen C et al. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 1998 111 : 25 30.
59. Cotsarelis G, Millar SE. Towards a molecular understanding of hair loss and its treatment. Trends Mol Med 2001 7 : 293 301.